These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 25031895)

  • 1. Letter: Diagnostic Whole-Body Scan May Not Be Necessary for Intermediate-Risk Patients with Differentiated Thyroid Cancer after Low-Dose (30 mCi) Radioactive Iodide Ablation (Endocrinol Metab 2014;29:33-9, Eon Ju Jeon et al.).
    Jung CH
    Endocrinol Metab (Seoul); 2014 Jun; 29(2):206-7. PubMed ID: 25031895
    [No Abstract]   [Full Text] [Related]  

  • 2. Response: Diagnostic Whole-Body Scan May Not Be Necessary for Intermediate-Risk Patients with Differentiated Thyroid Cancer after Low-Dose (30 mCi) Radioactive Iodide Ablation (Endocrinol Metab 2014;29:33-9, Eon Ju Jeon et al.).
    Jeon EJ; Jung ED
    Endocrinol Metab (Seoul); 2014 Jun; 29(2):208-9. PubMed ID: 25031896
    [No Abstract]   [Full Text] [Related]  

  • 3. Diagnostic Whole-Body Scan May Not Be Necessary for Intermediate-Risk Patients with Differentiated Thyroid Cancer after Low-Dose (30 mCi) Radioactive Iodide Ablation.
    Jeon EJ; Jung ED
    Endocrinol Metab (Seoul); 2014 Mar; 29(1):33-9. PubMed ID: 24741452
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Letter: a1c variability can predict coronary artery disease in patients with type 2 diabetes with mean a1c level greater than 7 (endocrinol metab 2013;28:125-32, eun ju lee et Al.).
    Jung HS
    Endocrinol Metab (Seoul); 2013 Dec; 28(4):346-7. PubMed ID: 24396702
    [No Abstract]   [Full Text] [Related]  

  • 5. Preablation Diagnostic Whole-Body Scan vs Empiric Radioactive Iodine Ablation in Differentiated Thyroid Cancer: Cost-effectiveness Analysis.
    Arjani S; Quinn PL; Chokshi RJ
    Otolaryngol Head Neck Surg; 2021 Jun; 164(6):1172-1178. PubMed ID: 33076776
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Letter: Long-Term Outcomes Following Thermal Ablation of Benign Thyroid Nodules as an Alternative to Surgery: The Importance of Controlling Regrowth (
    Kim TY
    Endocrinol Metab (Seoul); 2019 Sep; 34(3):323-324. PubMed ID: 31565885
    [No Abstract]   [Full Text] [Related]  

  • 7. Comparable Ablation Efficiency of 30 and 100 mCi of I-131 for Low to Intermediate Risk Thyroid Cancers Using Triple Negative Criteria.
    Fatima N; Zaman MU; Zaman A; Zaman U; Tahseen R
    Asian Pac J Cancer Prev; 2016; 17(3):1115-8. PubMed ID: 27039734
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Low-dose radioiodine therapy for patients with intermediate- to high-risk differentiated thyroid cancer.
    Abe K; Ishizaki U; Ono T; Horiuchi K; Kanaya K; Sakai S; Okamoto T
    Ann Nucl Med; 2020 Feb; 34(2):144-151. PubMed ID: 31834567
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A randomized clinical trial comparing 50mCi and 100mCi of iodine-131 for ablation of differentiated thyroid cancers.
    Zaman Mu; Toor R; Kamal S; Maqbool M; Habib S; Niaz K
    J Pak Med Assoc; 2006 Aug; 56(8):353-6. PubMed ID: 16967785
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Determining patient selection tool and response predictor for outpatient 30 mCi radioiodine ablation dose in non-metastatic differentiated thyroid carcinoma: a Japanese perspective.
    Higuchi T; Achmad A; Binh DD; Bhattarai A; Tsushima Y
    Endocr J; 2018 Mar; 65(3):345-357. PubMed ID: 29343651
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Response: a1c variability can predict coronary artery disease in patients with type 2 diabetes with mean a1c level greater than 7 (endocrinol metab 2013;28:125-32, eun ju lee et Al.).
    Lee EJ; Kim MK
    Endocrinol Metab (Seoul); 2013 Dec; 28(4):348-9. PubMed ID: 24396703
    [No Abstract]   [Full Text] [Related]  

  • 12. Letter: insufficient experience in thyroid fine-needle aspiration leads to misdiagnosis of thyroid cancer (endocrinol metab 2014;29:293-9, jung IL son et Al.).
    Yi HS; Lee S
    Endocrinol Metab (Seoul); 2014 Dec; 29(4):590-1. PubMed ID: 25559579
    [No Abstract]   [Full Text] [Related]  

  • 13. Extensive papillary carcinoma of the thyroid gland treated by external beam radiotherapy, surgery and postoperative radioactive iodine therapy.
    Naveed A; Kanaan F; Tjernstrom NO
    Eur Arch Otorhinolaryngol; 2009 Nov; 266(11):1837-9. PubMed ID: 19294401
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of different doses of radioactive iodine for remnant ablation on successful ablation and on long-term recurrences in patients with differentiated thyroid carcinoma.
    Kim EY; Kim TY; Kim WG; Yim JH; Han JM; Ryu JS; Hong SJ; Yoon JH; Gong G; Kim WB; Shong YK
    Nucl Med Commun; 2011 Oct; 32(10):954-9. PubMed ID: 21849927
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Role of [(18)F]-fluorodeoxy-D-glucose positron emission tomography and computed tomography in the early detection of persistent/recurrent thyroid carcinoma in intermediate-to-high risk patients following initial radioactive iodine ablation therapy.
    Kim MH; O JH; Ko SH; Bae JS; Lim DJ; Kim SH; Baek KH; Lee JM; Kang MI; Cha BY; Lee KW
    Thyroid; 2012 Feb; 22(2):157-64. PubMed ID: 22224820
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Absence of thyroid stunning after diagnostic whole-body scanning with 185 MBq 131I.
    Cholewinski SP; Yoo KS; Klieger PS; O'Mara RE
    J Nucl Med; 2000 Jul; 41(7):1198-202. PubMed ID: 10914909
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficacy of Low-dose and High-dose Radioactive Iodine Ablation With rhTSH in Korean Patients With Differentiated Thyroid Carcinoma: The First Report in Nonwestern Countries.
    Joung JY; Choi JH; Cho YY; Kim NK; Sohn SY; Kim SW; Chung JH
    Am J Clin Oncol; 2016 Aug; 39(4):374-8. PubMed ID: 24732812
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Letter to the Editor: Hypothyroidism Following Hemithyroidectomy: Incidence, Risk Factors, and Clinical Characteristics (Ahn D, Sohn JH, Jeon JH. Hypothyroidism following hemithyroidectomy: Incidence, risk factors, and clinical characteristics. J Clin Endocrinol Metab. 2016;101(4):1429-1436.).
    Choy KW; Choy KH
    J Clin Endocrinol Metab; 2016 Oct; 101(10):L93. PubMed ID: 27702319
    [No Abstract]   [Full Text] [Related]  

  • 19. Letter: Thyroid Stimulating Hormone Reference Range and Prevalence of Thyroid Dysfunction in the Korean Population: Korea National Health and Nutrition Examination Survey 2013 to 2015 (Endocrinol Metab 2017;32:106-14, Won Gu Kim et al.).
    Lee YK; Shin DY
    Endocrinol Metab (Seoul); 2017 Jun; 32(2):302-303. PubMed ID: 28685519
    [No Abstract]   [Full Text] [Related]  

  • 20. Letter: natural course of cytologically benign thyroid nodules: observation of ultrasonographic changes (endocrinol metab 2013;28:110-8, dong jun lim et Al.).
    Cho SW
    Endocrinol Metab (Seoul); 2013 Sep; 28(3):241-2. PubMed ID: 24396686
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.